StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by coalbeton Mar 14, 2019 9:21am

111 Views

Post# 29484215

level 2

GENENEWS LIMITED (CA:GEN)
Size	Bid	Ask	Size
182500	0.145	0.145	4000
290000	0.140	0.150	9000
218000	0.135	0.155	11000
394500	0.130	0.160	238000
48500	0.125	0.165	166000

Previous 10 Trades
Time	Size	Price
15:59:59	2000	0.150
15:56:23	500	0.150
15:55:17	1000	0.150
15:55:17	43000	0.150
15:55:17	24500	0.150
15:55:17	16000	0.150
15:55:10	500	0.155
15:54:51	500	0.150
15:52:39	25500	0.150
15:51:54	500	0.150